Provenier F, van Acker R, Backers J, van Wassenhove E, de Meyer V, Jordaens L
Department of Cardiology, University Hospital, Ghent, Belgium.
Pacing Clin Electrophysiol. 1992 Nov;15(11 Pt 2):1821-5. doi: 10.1111/j.1540-8159.1992.tb02975.x.
The Topaz model 515 (Vitatron B.V.) is a dual sensor rate responsive pacemaker for single chamber stimulation. It can be driven by activity counts (ACT) and QT interval measurements. Inappropriate rate modulation due to one sensor can be corrected by "sensor cross-checking." It was implanted in ten patients (20-86 years) of whom seven had complete heart block and atrial arrhythmias. After implantation T-wave amplitude ranged from 0.9 mV-3.5 mV. T-wave sensing ranged from 88%-99% in 9/10 patients at the follow-up of 3 weeks. Eight patients remained in default setting of the activity threshold, after evaluation with a short walking test. An exercise test was performed on all patients. In one test, QT sensing was marginal because of lead implantation in the right ventricular outflow tract. Therefore, this pacing rate was only modulated by ACT sensing. All others were tested with equal contribution of information from both sensors (ACT = QT). In 7/9, rate response was satisfactory. When the treadmill was repeated with ACT in five of these seven patients, rate generally accelerated too fast. In one patient the setting was adjusted to "QT > ACT," because of inappropriate acceleration due to activity sensing, in another it was adjusted to "QT < ACT" because of delayed response to activity. The pacing rate and the ACT during treadmill tests in "QT = ACT" mode were more closely correlated in the first 3 minutes, compared with the last 3 minutes. We feel that rate modulation with this new pacemaker is adequate. Sensor blending and sensor cross-checking are of clinical importance.
托帕兹515型起搏器(Vitatron B.V.公司)是一款用于单腔刺激的双传感器频率应答式起搏器。它可由活动计数(ACT)和QT间期测量值驱动。因一个传感器导致的不适当频率调制可通过“传感器交叉检查”来校正。该起搏器植入了10名患者(年龄在20至86岁之间),其中7名患有完全性心脏传导阻滞和房性心律失常。植入后T波振幅范围为0.9毫伏至3.5毫伏。在3周的随访中,9/10的患者T波感知率在88%至99%之间。在通过短距离步行测试评估后,8名患者保持活动阈值的默认设置。对所有患者都进行了运动测试。在一次测试中,由于导线植入右心室流出道,QT感知处于临界状态。因此,该起搏频率仅由ACT感知进行调制。其他所有患者都在两个传感器信息贡献相等(ACT = QT)的情况下进行了测试。在7/9的患者中,频率应答令人满意。在这7名患者中的5名患者再次进行跑步机测试且仅使用ACT时,频率通常加速过快。在一名患者中,由于活动感知导致的不适当加速,设置调整为“QT > ACT”,在另一名患者中,由于对活动的反应延迟,设置调整为“QT < ACT”。与最后3分钟相比,在“QT = ACT”模式下跑步机测试期间的起搏频率与ACT在前3分钟的相关性更强。我们认为这款新型起搏器的频率调制是足够的。传感器融合和传感器交叉检查具有临床重要性。